Onychomycosis in Psoriatic Patients with Nail Disorders: Aetiological Agents and Immunosuppressive Therapy

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Data</td><td class="align_center">Number</td><td class="align_center">Frequency (%)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Onychomycosis confirmed</td><td class="align_center">22</td><td class="align_center">57.9</td></tr><tr><td class="align_left">Positive direct mycological</td><td class="align_center">17</td><td class="align_center">44.8</td></tr><tr><td class="align_left">Positive anatomopathological</td><td class="align_center">12</td><td class="align_center">31.6</td></tr><tr><td class="align_left">Positive culture</td><td class="align_center">16</td><td class="align_center">42.1</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Frequency of onychomycosis and laboratory results of nail analysis of psoriatic patients.</div>

Dermatology Research and Practice

tab2

Table 2

Table 2: Onychomycosis in Psoriatic Patients with Nail Disorders: Aetiological Agents and Immunosuppressive Therapy 